Accepting applications until August 1

City of Hope Intensive Course in Genomic Cancer Risk Assessment

Accepting applications until August 1

Newsroom

Marco Maruzzo: Network Meta-Analysis Reveals the Optimal Perioperative Strategies for MIBC

Marco Maruzzo: Network Meta-Analysis Reveals the Optimal Perioperative Strategies for MIBC

Marco Maruzzo, Head of the Oncology 3 Unit and Medical Oncology Consultant specializing in genitourinary (GU) cancer at Veneto Institute of Oncology IOV – IRCCS, shared on LinkedIn: “The perioperative … Read More

Jul 26, 2026

Arturo LoAIza-Bonilla: Welcoming Shivani Shukla to St. Luke’s University Health Network

Arturo LoAIza-Bonilla: Welcoming Shivani Shukla to St. Luke’s University Health Network

Arturo LoAIza-Bonilla, Systemwide Chief of Hematology and Oncology at St. Luke’s University Health Network, shared on LinkedIn: “Welcoming Shivani Shukla to St. Luke’s University Health Network and as the newest team … Read More

Jul 26, 2026

Nabil Ismaili: The Era of Precision Oncology in Urothelial Carcinoma Has Truly Arrived

Nabil Ismaili: The Era of Precision Oncology in Urothelial Carcinoma Has Truly Arrived

Nabil Ismaili, Director of Medical Oncology and Radiotherapy Department at Mohammed VI University of Sciences and Health, shared on LinkedIn: “Thrilled to share that our editorial “Emergence of HER2 as … Read More

Jul 26, 2026

Sumanta Pal: KCRS26 Key Updates and Expert Takeaways

Sumanta Pal: KCRS26 Key Updates and Expert Takeaways

Sumanta Pal, Professor and Vice Chair of Academic Affairs, City of Hope, shared on X: “I love following Katy Beckermann on X and wonderful to see her deliver comments live … Read More

Jul 26, 2026

Enrique Grande: RAMPART Delivers a Critical Reality Check for Adjuvant Immunotherapy in RCC

Enrique Grande: RAMPART Delivers a Critical Reality Check for Adjuvant Immunotherapy in RCC

Enrique Grande, One Oncology Madrid Program Director of Quirónsalud, Adjunct Professor at The University of Texas MD Anderson Cancer Center, shared on LinkedIn: “Adjuvant durvalumab in RCC: what RAMPART tells us … Read More

Jul 25, 2026

Zara Baloch: How We Translate Cellular Therapy Progress Into Better, More Accessible Care

Zara Baloch: How We Translate Cellular Therapy Progress Into Better, More Accessible Care

Zara Baloch, Director of Quantitative Research and Meta Analysis, Digital Education Manager and Host at MedNews Week, Observer at HCA Houston Healthcare, shared a post on LinkedIn: “Cellular therapy is … Read More

Jul 25, 2026

Gilberto Lopes: Structured Summary and Critical Appraisal of ASCO26 Presentations on GLP-1 Agonists and Cancer

Gilberto Lopes: Structured Summary and Critical Appraisal of ASCO26 Presentations on GLP-1 Agonists and Cancer

Gilberto Lopes, Chief of the Division of Medical Oncology at the Sylvester Comprehensive Cancer Center, shared a post on X: “Curious about GLP-1 agonists and cancer? Here is a structured summary and … Read More

Jul 25, 2026

Myriam Chalabi: A New Treatment Window for MSS Colon Cancer

Myriam Chalabi: A New Treatment Window for MSS Colon Cancer

For more than two decades, the treatment pathway for localized colon cancer has remained largely unchanged. Most patients undergo surgery first, followed by a decision on adjuvant chemotherapy based on … Read More

Jul 25, 2026

ASCO Names 34 Oncology Leaders as 2027 FASCO Fellows

ASCO Names 34 Oncology Leaders as 2027 FASCO Fellows

The American Society of Clinical Oncology (ASCO) has recognized 34 oncology professionals with the 2027 Fellow of the American Society of Clinical Oncology designation, honoring their sustained service, engagement, and … Read More

Jul 25, 2026

Vincent Rajkumar: Five Tips for Delivering a Great Presentation in Medicine

Vincent Rajkumar: Five Tips for Delivering a Great Presentation in Medicine

Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared on X: “Being able to deliver a great talk/presentation is really important for academic success. Especially in medicine. 1) … Read More

Jul 25, 2026